• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供者动员前造血祖细胞计数可预测健康供者粒细胞集落刺激因子动员后外周血造血干细胞采集物中 CD34+细胞的产量。

Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.

机构信息

Department of Pediatrics, Hualien Buddhist Tzu-Chi General Hospital, Hualien, Taiwan.

出版信息

Transfusion. 2010 May;50(5):1088-95. doi: 10.1111/j.1537-2995.2009.02546.x. Epub 2009 Dec 29.

DOI:10.1111/j.1537-2995.2009.02546.x
PMID:20051055
Abstract

BACKGROUND

The hematopoietic progenitor cell (HPC) count measured by the Sysmex hematology analyzer can determine the timing for leukapheresis in autologous peripheral blood stem cell (PBSC) harvest. We evaluated whether a HPC count could predict CD34+ cell yield in healthy, unrelated donors after granulocyte-colony-stimulating factor mobilization.

STUDY DESIGN AND METHODS

A total of 117 healthy donors underwent 161 PBSC leukapheresis procedures in our institution. The HPCs and CD34+ cells were identified by an automated hematology analyzer and flow cytometry, respectively. Using Spearman's rank test, we evaluated the relationships between preharvest HPCs, CD34+ cell counts, and CD34+ cell yields in the apheresis product. A receiver operating characteristic (ROC) curve analysis was used to identify the cutoff value of HPC for adequate mobilization and harvest yield.

RESULTS

The HPC count had a moderate correlation with the preharvest CD34+ cell count (r = 0.502, p < 0.001), and an HPC count of more than 21.3 x 10(6)/L could exclude poor mobilization (<20 x 10(6) CD34+ cells/L) with sensitivity and specificity of 89.2 and 83.3%. However, the relationship between HPC count and CD34+ cell yield was not marked (r = 0.321, p < 0.001). The area under the curve for HPCs was significantly smaller than the preharvest CD34+ cell count on the ROC curve for predicting adequate harvest yield (>10 x 10(6) CD34+ cells/L of processed blood volume, 0.678 vs. 0.850, p = 0.001).

CONCLUSION

Although the preapheresis HPC count could predict mobilization in healthy donors before leukapheresis, it may not be a superior index for predicting CD34+ cell yield compared with the preharvest CD34+ cell count.

摘要

背景

Sysmex 血液分析仪检测到的造血祖细胞 (HPC) 计数可确定自体外周血造血干细胞 (PBSC) 采集时进行白细胞分离术的时间。我们评估了在粒细胞集落刺激因子动员后,HPC 计数是否可以预测健康无关供者采集后的 CD34+ 细胞产量。

研究设计和方法

共有 117 名健康供者在我们机构接受了 161 次 PBSC 白细胞分离术。HPC 与 CD34+细胞分别通过自动血液分析仪和流式细胞术鉴定。采用 Spearman 秩检验评估了收获前 HPC 与 CD34+细胞计数和收获产物中 CD34+细胞产量之间的关系。采用受试者工作特征 (ROC) 曲线分析确定 HPC 的截止值,以评估充分动员和收获产量。

结果

HPC 计数与收获前 CD34+细胞计数呈中度相关(r = 0.502,p < 0.001),HPC 计数>21.3 x 10(6)/L 可排除动员不良(<20 x 10(6) CD34+细胞/L),其敏感性和特异性分别为 89.2%和 83.3%。然而,HPC 计数与 CD34+细胞产量之间的关系并不显著(r = 0.321,p < 0.001)。HPC 曲线下面积显著小于 ROC 曲线中预测收获产量的 CD34+细胞计数(收获后每处理血容量中>10 x 10(6) CD34+细胞,0.678 与 0.850,p = 0.001)。

结论

尽管收获前的 HPC 计数可预测白细胞分离术前健康供者的动员情况,但与收获前 CD34+细胞计数相比,它可能不是预测 CD34+细胞产量的更好指标。

相似文献

1
Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.供者动员前造血祖细胞计数可预测健康供者粒细胞集落刺激因子动员后外周血造血干细胞采集物中 CD34+细胞的产量。
Transfusion. 2010 May;50(5):1088-95. doi: 10.1111/j.1537-2995.2009.02546.x. Epub 2009 Dec 29.
2
Hematopoietic progenitor cell counts performed by the Sysmex SE-9000 analyzer can guide timing of peripheral blood stem cell harvest.Sysmex SE - 9000分析仪进行的造血祖细胞计数可指导外周血干细胞采集的时机。
Anticancer Res. 2001 Jan-Feb;21(1B):601-4.
3
Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.外周血循环未成熟细胞计数可预测健康供者在粒细胞集落刺激因子诱导的外周血造血干细胞动员中CD34+细胞的产量。
Transfusion. 2004 Apr;44(4):526-32. doi: 10.1111/j.1537-2995.2004.03078.x.
4
Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.Sysmex检测的造血祖细胞计数与不同动员方案后CD34+细胞采集产量之间的相关性。
J Cancer Res Clin Oncol. 2002 Jul;128(7):380-4. doi: 10.1007/s00432-002-0351-4. Epub 2002 Jun 13.
5
Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.健康供体中与粒细胞集落刺激因子诱导的外周血干细胞产量相关的因素。
Vox Sang. 2005 Nov;89(4):229-35. doi: 10.1111/j.1423-0410.2005.00701.x.
6
HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34(+) measurements and timing of leukaphereses.使用Sysmex XE - 2100进行造血祖细胞计数可指导进一步的流式细胞仪CD34(+)测量以及白细胞单采术的时机。
Cytotherapy. 2003;5(5):414-9. doi: 10.1080/14653240310003071.
7
Use of the haematopoietic progenitor cell parameter in optimizing timing of peripheral blood stem cell harvest.造血祖细胞参数在优化外周血干细胞采集时机中的应用。
Vox Sang. 2009 Aug;97(2):153-9. doi: 10.1111/j.1423-0410.2009.01183.x. Epub 2009 Apr 9.
8
Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.SE自动血液分析仪测定的造血祖细胞计数与白细胞单采制品中通过流式细胞术检测的CD34(+)细胞计数的相关性。
Am J Hematol. 2001 May;67(1):42-7. doi: 10.1002/ajh.1074.
9
Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.从健康供体在给予粒细胞集落刺激因子后采集的单采白细胞分离产品中,长期重建造血祖细胞的数量比传统骨髓同种异体移植高十倍。
Bone Marrow Transplant. 1999 Feb;23(3):243-9. doi: 10.1038/sj.bmt.1701579.
10
Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest.造血祖细胞计数在预测外周血干细胞采集最佳时机方面的临床实用性。
J Korean Med Sci. 2003 Feb;18(1):27-35. doi: 10.3346/jkms.2003.18.1.27.

引用本文的文献

1
Population Pharmacokinetic-Pharmacodynamic Modeling of Granulocyte Colony-Stimulating Factor to Optimize Dosing and Timing for CD34 Cell Harvesting.粒细胞集落刺激因子的群体药代动力学-药效学建模以优化CD34细胞采集的给药剂量和时间。
Clin Transl Sci. 2025 Jan;18(1):e70121. doi: 10.1111/cts.70121.
2
Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation.初诊自体干细胞移植后多发性骨髓瘤患者早期疾病进展和生存降低的风险因素。
Ann Hematol. 2024 Aug;103(8):2893-2904. doi: 10.1007/s00277-024-05641-y. Epub 2024 Mar 13.
3
Long-term follow-up of cancer and catastrophic diseases in hematopoietic stem cell donors: a comprehensive matched cohort study.
造血干细胞供者中癌症和灾难性疾病的长期随访:一项全面匹配队列研究。
Bone Marrow Transplant. 2024 Jun;59(6):849-857. doi: 10.1038/s41409-024-02204-7. Epub 2024 Mar 7.
4
Efficacy and Safety of Single-dose Pegfilgrastim for CD34 + Cell Mobilization in Healthy Volunteers: A Phase 2 Study.单剂量聚乙二醇化非格司亭在健康志愿者中 CD34+细胞动员的疗效和安全性:一项 2 期研究。
Transplantation. 2024 Apr 1;108(4):996-1003. doi: 10.1097/TP.0000000000004880. Epub 2024 Mar 23.
5
Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients.多发性骨髓瘤患者干细胞动员失败的危险因素及结局
Transfus Med Hemother. 2022 Sep 5;50(1):39-50. doi: 10.1159/000525565. eCollection 2023 Feb.
6
Assessment of haematopoietic progenitor cell counting with the Sysmex XN-1000 to guide timing of apheresis of peripheral blood stem cells.评估 Sysmex XN-1000 检测造血祖细胞计数以指导外周血造血干细胞采集时机。
Blood Transfus. 2020 Jan;18(1):67-76. doi: 10.2450/2019.0086-19. Epub 2019 Jul 25.
7
Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with β-thalassemia major.干细胞采集不佳未必总是与动员效果不佳相关:从一项针对重型β地中海贫血患者的动员研究中获得的经验教训。
Transfusion. 2017 Apr;57(4):1031-1039. doi: 10.1111/trf.13951. Epub 2016 Dec 17.
8
Circulating hematopoietic progenitors and CD34(+) cells predicted successful hematopoietic stem cell harvest in myeloma and lymphoma patients: experiences from a single institution.循环造血祖细胞和CD34(+)细胞可预测骨髓瘤和淋巴瘤患者造血干细胞采集的成功:来自单一机构的经验
J Blood Med. 2016 Feb 5;7:5-11. doi: 10.2147/JBM.S95679. eCollection 2016.
9
Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.新型自动化造血祖细胞分析在外周血干细胞采集临床管理中的评估
Transfusion. 2015 Aug;55(8):2001-9. doi: 10.1111/trf.13078. Epub 2015 Mar 21.